Delivery Order SPE2DR25D9168-SPE2DR26FCSG5
Award Date 3/23/26
Potential Completion Date 3/24/26
Potential Value $5.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, for VABYSMO 6 mg/0.05 mL syringes, with a ceiling value of $8,821.68 and an ultimate completion date of March 24, 2026. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that provides firm fixed-price...
- The Defense Logistics Agency issued a $11,762.24 delivery order to DMS Pharmaceutical Group Inc. on March 11, 2026, for VABYSMO 6 mg/0.05 mL syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic pharmaceuticals, biologics, and medical consumables to Department of Defense military healthcare facilities worldwide. The parent IDC, awarded to DMS...
- The Defense Logistics Agency issued a $1,197.85 delivery order to DMS Pharmaceutical Group Inc. on March 12, 2026, for VABYSMO 6MG/0.05ML pharmaceutical product under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is placed under the PPV-G GEN V indefinite delivery contract, a Defense Logistics Agency pharmaceutical prime vendor program authorizing firm fixed-price delivery...
- The Defense Logistics Agency issued a $65,066.40 delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense medical facilities worldwide; DMS Pharmaceutical Group's...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 16, 2026, with a ceiling value of $8,821.68 for VABYSMO 6 mg/0.05 mL syringes. The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling authorizing DLA to issue firm fixed-price delivery orders for pharmaceutical products and medical consumables to support...
- The Defense Logistics Agency issued a $4,966.25 delivery order to DMS Pharmaceutical Group Inc. on March 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. DMS Pharmaceutical Group Inc. is a woman-owned small business. The parent contract, PPV-G GEN V, is a Defense Logistics Agency Indefinite Delivery Contract with a ceiling value of $499,999,999 and an ultimate completion date of December 31, 2036, supporting recurring...
- The Defense Logistics Agency issued a $138,412.45 delivery order to DMS Pharmaceutical Group Inc. on March 13, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical and medical consumables supply. DMS Pharmaceutical Group Inc. is a woman-owned small business. The parent contract, PPV-G GEN V, is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 10, 2026, for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), with a ceiling value of $4,361.95. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is placed against the company's single-award Indefinite Delivery Contract under the Defense Logistics Agency's PPV-G GEN V initiative, a $499.999 billion...
- The Defense Logistics Agency issued a $139,930.12 delivery order to DMS Pharmaceutical Group Inc. on March 23, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is placed against the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price calls for branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency issued a $3,863.68 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products supporting Department of Defense medical supply needs. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is firm fixed price with place of performance in Park Ridge, Illinois. Ultimate completion is March 4, 2026. The ceiling value equals the obligated...